- Home
- EVAX vs ONFO Comparison
EVAX vs ONFO Comparison
Compare EVAX & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- ONFO
- Stock Information
- Founded
- EVAX 2008
- ONFO 2018
- Country
- EVAX Denmark
- ONFO United States
- Employees
- EVAX N/A
- ONFO N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- ONFO Computer Software: Programming Data Processing
- Sector
- EVAX Health Care
- ONFO Technology
- Exchange
- EVAX Nasdaq
- ONFO Nasdaq
- Market Cap
- EVAX 17.8M
- ONFO 5.0M
- IPO Year
- EVAX 2021
- ONFO 2022
- Fundamental
- Price
- EVAX $2.93
- ONFO $1.11
- Analyst Decision
- EVAX Strong Buy
- ONFO
- Analyst Count
- EVAX 2
- ONFO 0
- Target Price
- EVAX $10.00
- ONFO N/A
- AVG Volume (30 Days)
- EVAX 68.5K
- ONFO 1.7M
- Earning Date
- EVAX 10-30-2025
- ONFO 11-14-2025
- Dividend Yield
- EVAX N/A
- ONFO N/A
- EPS Growth
- EVAX N/A
- ONFO N/A
- EPS
- EVAX N/A
- ONFO N/A
- Revenue
- EVAX $3,176,000.00
- ONFO $10,508,728.00
- Revenue This Year
- EVAX N/A
- ONFO N/A
- Revenue Next Year
- EVAX $425.50
- ONFO N/A
- P/E Ratio
- EVAX N/A
- ONFO N/A
- Revenue Growth
- EVAX 1042.45
- ONFO 78.36
- 52 Week Low
- EVAX $1.20
- ONFO $0.61
- 52 Week High
- EVAX $16.69
- ONFO $1.95
- Technical
- Relative Strength Index (RSI)
- EVAX 51.89
- ONFO 51.59
- Support Level
- EVAX $2.81
- ONFO $0.98
- Resistance Level
- EVAX $3.04
- ONFO $1.95
- Average True Range (ATR)
- EVAX 0.21
- ONFO 0.14
- MACD
- EVAX -0.00
- ONFO 0.02
- Stochastic Oscillator
- EVAX 68.64
- ONFO 17.65
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.